Home › Funds › SHEN NEIL NANPENG › BNR

SHEN NEIL NANPENG position in BNR

BURNING ROCK BIOTECH LTD · Health Care

SHEN NEIL NANPENG reported holding 885 shares of BNR (BURNING ROCK BIOTECH LTD) in its Q4 2025 13F filing — a position valued at US$36K, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. SHEN NEIL NANPENG has disclosed BNR holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

Latest position (Q4 2025)885 sh
Reported value held$36.34K
Portfolio Weight100.00%
First reportedQ3 2023
Last changeHold
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How SHEN NEIL NANPENG's BNR position evolved

SHEN NEIL NANPENG first disclosed a stake in BNR in Q3 2023 at 885 shares (US$1K). The position peaked in Q4 2025 at 885 shares, worth US$36K. Across 10 filings, SHEN NEIL NANPENG held the position steady without any share-count change. The most recent filing (Q4 2025) shows 885 shares valued at US$36K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 885 $858 New
Q4 2023 885 $841 Hold
Q1 2024 885 $761 Hold
Q2 2024 885 $761 Hold
Q3 2024 885 $5.65K Hold
Q4 2024 885 $5.65K Hold
Q1 2025 885 $2.60K Hold
Q2 2025 885 $2.80K Hold
Q3 2025 885 $8.98K Hold
Q4 2025 885 $36.34K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNR and 13F data

BNR (BURNING ROCK BIOTECH LTD) is a Health Care company. 18 other funds we track also report a position in BNR — the largest reported positions include Kynam Capital Management, LP (US$10.5M), CRCM LP (US$1.8M), HSG Holding Ltd (US$178K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNR

All BNR fund holders →

FAQ

How long has SHEN NEIL NANPENG held BNR?

SHEN NEIL NANPENG has disclosed BNR holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

What is SHEN NEIL NANPENG's current position in BNR?

As of Q4 2025, SHEN NEIL NANPENG holds 885 shares of BNR (BURNING ROCK BIOTECH LTD), valued at $36.34K, representing 100.00% of its reported portfolio and ranking #1.

Has SHEN NEIL NANPENG been buying or selling BNR?

In the latest 13F filing (Q4 2025), SHEN NEIL NANPENG held unchanged its position in BNR. The position peaked in Q4 2025 at 885 shares.

Which other funds hold BNR?

Other major institutional holders of BNR include Kynam Capital Management, LP, CRCM LP, HSG Holding Ltd, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.